Jonathan Lewis, MD, PhD

Media Releases

Where Precision Meets Impact: Pioneering Immunotherapies that Revolutionize Cancer Treatment

Dr. Jonathan Lewis has joined Syncromune as the Chief Strategy Officer, bringing his wealth of experience in cancer research and immunotherapies to lead the development of an innovative in situ platform therapy for metastatic solid tumor cancers. Syncromune, a clinical-stage biopharmaceutical company, aims to revolutionize cancer treatment with high response rates and potentially improved survival outcomes.

With a distinguished career in global translational and clinical research, Dr. Lewis has held key leadership positions at renowned biopharmaceutical companies. As the former Executive Chairman, CEO, and Chief Medical Officer of Ziopharm Oncology, he spearheaded the development of groundbreaking immunotherapies for metastatic cancers. Prior to that, he served as Chairman and Chief Medical Officer of Antigenics, Inc, focusing on personalized therapeutic vaccines for various diseases.

Dr. Lewis is a highly respected figure in the medical and scientific community, serving as Chairman of three boards and Director of two others. His educational background includes an M.D. from Witwatersrand University and a Ph.D. from Yale University, with additional training at esteemed institutions such as The Royal College of Surgeons in Edinburgh, Cambridge University, and Memorial Sloan-Kettering Cancer Center.

At Memorial Sloan-Kettering Cancer Center in New York, Dr. Lewis made significant contributions as an attending surgeon in the Department of Surgery and as an attending physician in the Clinical Immunology Service, Division of Hematologic Oncology. He also held a professorship at Weill Medical College of Cornell University, and currently serves as an Adjunct Professor at Lankenau Institute for Medical Research.

Recognized for his exceptional leadership and fundraising abilities, Dr. Lewis has raised over 1 billion US dollars in equity, nonprofit, and government funding. His achievements have been acknowledged with prestigious honors and awards in medicine and science, including the ASCO Young Investigator Award, the Kristen Carr Fellowship, the Yale University Ohse Fellowship, the Royal College of Surgeons Trubshaw Medal, the University of Cambridge Churchill Fellowship, the inaugural Kristen Ann Carr Fellowship, and the Sarcoma Foundation of America Hope and Vision Award. His extensive research has led to over 200 scientific publications and contributions to numerous textbooks in the field of cancer biology and treatment.

Syncromune is thrilled to welcome Dr. Jonathan Lewis to its team as Chief Strategy Officer, confident that his expertise and vision will drive the company towards developing innovative cancer therapies that have the potential to transform patient outcomes.

Recommended Articles

• 5 Tips on Living with Lung Cancer

  Lung cancer, also known as lung carcinoma, is a malignant lung tumor depicted by uncontrolled cell growth in tissues of the lung. If left untreated, this growth can spread beyond the lung by the process of metastasis into nearby tissue or other parts of the body.The following are 5 tips on...

• Bone Health Drugs for Breast Cancer

  Like any other drug or therapy, breast cancer treatment also has its own side effects. One of the side effects of breast cancer treatment is rapid bone loss leading to osteoporosis. The following are treatments for breast cancer that can significantly cause bone loss:...

• This Ovarian Cancer Treatment Gives Patients Freedom During Chemotherapy

  PARP inhibitors are making a big difference to cancer patients. Since they are administered orally, patients have the freedom to take them at home, and aren’t restricted by hospital visits for chemotherapy. Here’s Laurie McAndrews’s story.In December 2014, Laurie McAndrews from Illinois was...

• What Are Night Sweats: Get the Facts

  What are night sweats?Night sweats are also called as nocturnal hyperhidrosis, which means excessive sweating during the night. Night sweats are episodes of continuous sweating at night even when the environmental temperature is very cold. Some people may sweat so extensively that they might find...

• Are There Routine Checks for Ovarian Cancer?

  Ovarian cancer is the most common cause of death among gynecologic types of cancer. The most common risk factors for ovarian cancer are:...

• Know the Symptoms of Cervical Cancer

  Cervical cancer gradually develops when the healthy cells lining the cervix change and grow out of control. These changes lead to the formation of a mass, which is called a tumor. The tumor can either be benign (a tumor that is harmless) or malignant (cancerous and spreads to other parts of the...